Brief: Cytodyn Inc Says COVID-19 Long-Haulers Study Is Now Fully Enrolled
08/04/2021 23:04
April 8 (Reuters) - Cytodyn Inc CYDY.PK :
* CYTODYN INC - COVID-19 LONG-HAULERS STUDY ("CD15") IS NOW
FULLY
ENROLLED
Source text for Eikon: ID:nGNXWrDzy
Further company coverage: CYDY.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cytodyn
See all newsBrief: Cytodyn Appoints Robert E. Hoffman As Chief Executive Officer
Brief: Cytodyn Closes $17.5 Million Financing To Fund Continued Development Of Leronlimab
Brief: CytoDyn Inc Files For Offering Of Up To 120 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Brief: Cytodyn Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer